About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in San Diego | 208 Studies

Clinical Trials Breast CancerSan Diego

Breast Cancer Clinical Trials in San Diego

Find 208 clinical trials for breast cancer near San Diego, California. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in San Diego

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 208 trials

Active not recruitingA Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsThis phase II trial studies cediranib maleate in combination with olaparib in treating patients with solid tumors that have spread to other parts of the body (advanced/metastatic)…NCT02498613·La Jolla, California and 15 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedCognition in the Study of Tamoxifen and RaloxifeneThe purpose of this study is to assess the effects of tamoxifen and raloxifene on cognitive aging in selected cognitively-healthy women.NCT00687102·Phoenix, Arizona and 133 others

Active not recruitingMRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In SituThis clinical trial studies magnetic resonance imaging (MRI) and gene expression in diagnosing patients with abnormal cells in the breast duct that have not spread outside the…NCT02352883·San Diego, California and 75 others

Approved for marketingExpanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) ActivationExpanded access for participants with cancer with RET activation who are ineligible for an ongoing selpercatinib (also known as LOXO-292) clinical trial or have other…NCT03906331·Goodyear, Arizona and 63 others

CompletedA Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb20717, to describe safety and tolerability, to assess PK and…NCT03517488·Los Angeles, California and 16 others

CompletedFirst-in-Human Dose Escalation Trial in Subjects With Advanced MalignanciesThis is a Phase 1, first-in-human, open-label, non-randomized, dose escalation, trial to explore the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) and clinical…NCT01971515·Birmingham, Alabama and 14 others

RecruitingFT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid TumorsThis is a Phase 1 study of FT836 administered in participants with advanced solid tumors.NCT07216105·La Jolla, California and 4 others

CompletedANG1005 in Breast Cancer Patients With Recurrent Brain MetastasesThis is a Phase 2 study to see if an investigational drug, ANG1005, can shrink tumor cells in breast cancer patients with recurrent brain metastases.NCT02048059·Tucson, Arizona and 18 others

CompletedDoxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast CancerThis randomized phase III trial studies doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and trastuzumab to see how well they work compared to combination chemotherapy…NCT00005970·Birmingham, Alabama and 156 others

CompletedImetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast CancerThe purpose of this study is to evaluate the efficacy and safety of treatment with imetelstat + paclitaxel (with or without bevacizumab) versus paclitaxel (with or without…NCT01256762·Huntsville, Alabama and 54 others

Active not recruitingA Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant giredestrant compared with physician's choice of endocrine…NCT04961996·Daphne, Alabama and 620 others

CompletedAn Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast CancerThis study is intended to evaluate the safety, tolerability, and possible effectiveness of an investigational humanized monoclonal antibody (CAL) to the parathyroid…NCT00051779·Little Rock, Arkansas and 37 others

Active not recruitingBreast Cancer WEight Loss Study (BWEL Study)This randomized phase III trial compares whether weight loss in overweight and obese women may prevent breast cancer from coming back (recurrence).NCT02750826·Daphne, Alabama and 1497 others

TerminatedVaccine-Based Immunotherapy Regimen For NSCLC and TNBCPart 1of the study will evaluate the safety, pharmacokinetics, pharmacodynamics and immunogenicity of increasing doses of a vaccine-based immunotherapy regimen (VBIR-2) for…NCT03674827·Encinitas, California and 33 others

CompletedFulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-PositiveThis randomized phase III trial studies fulvestrant and lapatinib to see how well they work compared to fulvestrant and a placebo in treating postmenopausal women with stage III…NCT00390455·Little Rock, Arkansas and 367 others

RecruitingRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors.NCT05579366·Phoenix, Arizona and 66 others

CompletedS9630, Medroxyprogesterone in Treating Women With Breast CancerRATIONALE: It is not yet known whether medroxyprogesterone is effective in preventing endometrial disorder in patients with breast cancer who are taking tamoxifen.NCT00002920·Mobile, Alabama and 121 others

RecruitingTesting Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM TrialThis phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has…NCT06500481·Phoenix, Arizona and 57 others

TerminatedA Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)This is a Phase 1b/2 dose-optimization study to evaluate safety, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of avelumab (MSB0010718C) in combination…NCT02554812·Encinitas, California and 87 others

RecruitingA Multi-Modality Surveillance Program for Women at High Risk for Breast CancerThis study is aimed to establish a registry of women undergoing intensive surveillance for the early detection of breast cancer in high-risk women.NCT03729115·La Jolla, California and 2 others

PreviousPage 5 of 11Next

Other Conditions in San Diego

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma